Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Rosiglitazone
100%
Glucose Metabolism
100%
Continuous Ambulatory Peritoneal Dialysis
100%
Diabetes
66%
Insulin Resistance
66%
Homeostatic Model Assessment
66%
Oral Glucose Tolerance Test
50%
C Reactive Protein
33%
Tumor Necrosis Factor
33%
Insulin Sensitivity
33%
Peritoneal Dialysis
33%
Interleukin 6
33%
Blood Pressure
16%
Cardiovascular Disease
16%
Body Weight
16%
Liver Function
16%
Hemoglobin A1c
16%
Blood Biochemistry
16%
Glucose Intolerance
16%
Dialysis Adequacy
16%
Vascular Disease
16%
Cardiovascular Risk
16%
Insulin Sensitizing Agent
16%
Parathyroid Hormone
16%
Nursing and Health Professions
Continuous Ambulatory Peritoneal Dialysis
100%
Rosiglitazone
100%
Homeostasis Model Assessment
66%
Insulin Resistance
66%
Oral Glucose Tolerance Test
50%
C Reactive Protein
33%
Tumor Necrosis Factor
33%
Interleukin 6
33%
Peritoneal Dialysis
33%
Insulin Sensitizing Agent
16%
Cardiovascular Risk
16%
Glucose Level
16%
Liver Level
16%
Body Weight
16%
Blood Pressure
16%
Glucose Intolerance
16%
Blood Biochemistry
16%
Hemoglobin Blood Level
16%
Insulin Level
16%
Hemoglobin A1c
16%
Vascular Disease
16%
Cardiovascular Disease
16%
Parathyroid Hormone
16%